ICD-10 Coding for Adrenal Cortical Adenoma(C74.0, C74.0M, D35.0)
Learn about adrenal cortical adenoma, its ICD-10 coding, documentation requirements, and clinical validation criteria. Ensure accurate coding and billing with our comprehensive guide.
Complete code families applicable to Adrenal Cortical Adenoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D35.01 | Benign neoplasm of right adrenal gland | Use when a benign adenoma is confirmed in the right adrenal gland. |
|
| D35.02 | Benign neoplasm of left adrenal gland | Use when a benign adenoma is confirmed in the left adrenal gland. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdrenal Cortical Adenoma
Alternative codes to consider when ruling out similar conditions
Use when the pathology report is inconclusive regarding benign or malignant status.
Documentation & Coding Risks
Avoid these common issues when documenting Adrenal Cortical Adenoma.
Vague documentation of adrenal mass
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Ensure detailed documentation of imaging and pathology findings., Use specific terminology like 'benign adenoma' with size and weight.
Confusing benign adenoma with carcinoma
Impact
Reimbursement: Incorrect coding may lead to inappropriate DRG assignment., Compliance: Misclassification can result in compliance issues., Data Quality: Affects the accuracy of clinical data and outcomes.
Mitigation
Verify histological confirmation and ensure documentation specifies 'benign'.
Misclassification of adrenal tumors
Impact
Risk of coding benign adenomas as malignant due to unclear documentation.
Mitigation
Ensure clear documentation of benign status with supporting pathology and imaging.